HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network.

AbstractOBJECTIVES:
To show discriminative power between patients with prostate cancer (PCa) and those with "no evidence of malignancy" using "benign" prostate-specific antigen (bPSA) and the new automated Access benign prostatic hyperplasia-associated (BPHA) research assay within a percent free PSA (%fPSA)-based artificial neural network (ANN) model.
METHODS:
The sera from 287 patients with PCa and 254 patients with no evidence of malignancy were measured using the BPHA, total PSA (tPSA), and fPSA assays with Access immunoassay technology, with a 0-10 ng/mL tPSA range. Two ANN models with Bayesian regularization and leave-one-out validation using the 4 input parameters of tPSA, %fPSA, age, and prostate volume and 1 containing BPHA/tPSA were constructed and compared by receiver operating characteristic curve analysis.
RESULTS:
The BPHA/tPSA-based ANN reached the significant greatest area under the receiver operating characteristic curve (AUC 0.81; P = .0004 and P = .0024) and best specificity (53.9% and 44.5%) compared with the ANN without BPHA/tPSA (AUC 0.77; specificity 50% and 40.6%) and %fPSA (AUC 0.77; specificity 40.9% and 27.2%) at 90% and 95% sensitivity, respectively. The AUCs for tPSA (0.58), BPHA (0.55), BPHA/fPSA (0.51), prostate volume (0.69), and BPHA/tPSA (0.69) were significantly lower.
CONCLUSIONS:
Although BPHA as single marker or ratio to tPSA did not improve the diagnostic performance of %fPSA or tPSA, the incorporation of BPHA/tPSA into an ANN model increased the specificity compared with %fPSA by 13% and 17% at 90% and 95% sensitivity, respectively. Thus, the automated BPHA research assay might improve PCa detection when incorporating this new marker into an ANN.
AuthorsCarsten Stephan, Henning Cammann, Serdar Deger, Mark Schrader, Hellmuth A Meyer, Kurt Miller, Michael Lein, Klaus Jung
JournalUrology (Urology) Vol. 74 Issue 4 Pg. 873-7 (Oct 2009) ISSN: 1527-9995 [Electronic] United States
PMID19476981 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Prostate-Specific Antigen
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Humans
  • Male
  • Middle Aged
  • Neural Networks, Computer
  • Prostate-Specific Antigen (blood)
  • Prostatic Hyperplasia (blood)
  • Prostatic Neoplasms (blood, diagnosis)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: